Fresenius Medical Care has seen 18.5% growth, with strong prospects. Learn why FMS stock’s fair value of $34/share makes it a ...

The dialysis market is projected to grow at a CAGR of approximately 8% during the forecast period. This growth is driven by ...

Learn more about whether Encompass Health Corporation or Fresenius Medical Care AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Weirton Dialysis is facing significant challenges due to ongoing water situation in Weirton, making it difficult for it to ...

Bank of America Securities analyst Marianne Bulot maintained a Hold rating on Fresenius Medical Care (FMS – Research Report) today. The ...

Now the company wants to bring a new standard of care in dialysis therapy to people living with kidney diseases in the U.S. Fresenius Medical Care (FME), the world's leading provider of products ...

Kepler Capital analyst Oliver Reinberg maintained a Buy rating on Fresenius SE & Co. KGaA (0OO9 – Research Report) on January 31 and set a ...